MTOR and cancer: Alteration of the PI3K/AKT/mTOR signaling pathway by either the mutation or amplification of genes participated in the PI3K pathway, overactivation of RTKs or loss of the tumor suppressor PTEN, has been noticed in several cancer cells, causal to tumor progression as well as metastasis [71,72,73,74].